Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LESTER P WANG

Allopathic & Osteopathic Physicians Urology

NPI
1497733984
CMS profile
339558
Location
KILLEEN, TX

General Payments · PY2021–2024

$1,215.45

  • Reported across 25 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$668.88

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $668.88 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
COLOPLAST CORP $201.59 4
BIOTISSUE HOLDINGS INC. $129.08 1
UROGEN PHARMA, INC. $123.64 1
Checkpoint Surgical, Inc $40.63 1
Cook Medical LLC $35.89 1
Photocure Inc $35.56 1
AngioDynamics, Inc. $33.42 1
Ferring Pharmaceuticals Inc. $22.02 1
TOLMAR, INC. $16.40 1
IMMUNITYBIO, INC. $15.60 1
Antares Pharma, Inc. $15.05 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $25.24 1
PY2022 $237.80 5
PY2023 $283.53 5
PY2024 $668.88 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AngioDynamics, Inc. $33.42 12/17/2024 Food and Beverage Undisputed 01/23/2026 1095099878 CMS
Antares Pharma, Inc. $15.05 10/28/2024 Food and Beverage Undisputed 01/23/2026 1146491838 CMS
BIOTISSUE HOLDINGS INC. $129.08 12/03/2024 Food and Beverage Undisputed 01/23/2026 1148749556 CMS
Checkpoint Surgical, Inc $40.63 08/28/2024 Food and Beverage Undisputed 01/23/2026 1143875281 CMS
COLOPLAST CORP $157.63 01/30/2024 Food and Beverage Undisputed 01/23/2026 1117436975 CMS
COLOPLAST CORP $20.63 03/08/2024 Food and Beverage Undisputed 01/23/2026 1117437057 CMS
COLOPLAST CORP $3.76 04/25/2024 Food and Beverage Undisputed 01/23/2026 1117437075 CMS
COLOPLAST CORP $19.57 11/18/2024 Food and Beverage Undisputed 01/23/2026 1117437129 CMS
Cook Medical LLC $35.89 08/08/2024 Food and Beverage Undisputed 01/23/2026 1118339065 CMS
Ferring Pharmaceuticals Inc. $22.02 12/11/2024 Food and Beverage Undisputed 01/23/2026 1137517414 CMS
IMMUNITYBIO, INC. $15.60 10/16/2024 Food and Beverage Undisputed 01/23/2026 1125510542 CMS
Photocure Inc $35.56 10/04/2024 Food and Beverage Undisputed 01/23/2026 1119775843 CMS
Tolmar, Inc. $16.40 06/13/2024 Food and Beverage Undisputed 01/23/2026 1138704582 CMS
UROGEN PHARMA, INC. $123.64 05/16/2024 Food and Beverage Undisputed 01/23/2026 1137925800 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.